SCHEMBL3606208

SCHEMBL3606208

COc1ccc2c(c1)ncn2CC(=O)NCCNCC1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.44
POLB P06746 1/20 0.44
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
BRD4 O60885 1/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EPHX2 P34913 1/20 0.41
CDYL2 Q8N8U2 1/20 0.41
CDYL Q9Y232 1/20 0.41
CDY1; CDY1B Q9Y6F8 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HPGDS O60760 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367271 0.92 MTNR1A (0.53) TP53POLBMTNR1AMTNR1BBRD4
SCHEMBL3602189 0.87 HPGD (0.43) TP53POLBALDH1A1MAPTHPGD
SCHEMBL3597093 0.85 BACE1 (0.47) POLBALDH1A1HPGDMEN1KMT2A
SCHEMBL3599702 0.84 GRIN2B (0.41) TP53POLBALDH1A1HPGDMEN1
SCHEMBL3606205 0.83 TP53 (0.45) TP53MTNR1AMTNR1BBRD4ALDH1A1
SCHEMBL5345354 0.81 TRPA1 (0.44) TP53POLBALDH1A1HPGDMEN1
SCHEMBL3605823 0.81 HTT (0.42) POLBALDH1A1MAPTHPGDMEN1
SCHEMBL3644326 0.76 KDM4E (0.48) POLBMTNR1AMTNR1BALDH1A1HPGD
SCHEMBL5367265 0.76 MTNR1A (0.52) TP53MTNR1AMTNR1BALDH1A1MAPT
SCHEMBL3608393 0.75 PRPS1 (0.41) TP53POLBALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 TP53 1777/4885POLB 4479/4885MTNR1A 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.